Tier 1 — highest

Modulating stress and sleep through a multi-compound dietary supplement: a randomized, double-blind, placebo-controlled trial

Gianna F. Mastrofini, Riccardo F. Romersi, Maria G. Lombardi, Katelynn T. Persaud, Monica M. Ryan, Katie R. Hirsch, Amy L. Fraley, J. Jay Dawes, Sten O. Stray-Gundersen, James W. Hardin, Shawn M. Arent
Journal of the International Society of Sports Nutrition 2026 23(1):2740227

Bibliography

PubMed
PMID 42829807
PubMed Central
PMC13644447
Funding
Supported by Momentous LLC under Grant 10014583. Gianna F. Mastrofini was also supported in part by NIH-NIGMS Grant T32-GM081740.
Competing interests
The authors reported no potential conflict of interest. Finished study products were produced by Momentous LLC, which funded the study.

Study snapshot

DesignRandomized, double-blind, placebo-controlled four-group human trial
ModelHealthy physically active adults
Sample103 participants completed the study: AMPM n=25, AM n=26, PM n=25, placebo n=27
InterventionEvening active formula: 2 g magnesium L-threonate delivering 145 mg magnesium, 200 mg L-theanine and 50 mg apigenin from grapefruit; morning active formula: 600 mg ashwagandha plus 300 mg Rhodiola rosea. Four groups received combinations of active or placebo AM/PM products.
Duration4 weeks total: 1 baseline week, 2 supplementation weeks and 1 washout week
EndpointsPROMIS subjective sleep measures; Pittsburgh Sleep Quality Index; Wearable-derived objective sleep; Perceived stress; Positive affect; Wake after sleep onset

What the study showed, in plain terms

This 2026 randomized human trial included 50 mg of apigenin in an evening sleep formula together with magnesium L-threonate and L-theanine. It is the most directly relevant recent human supplement trial containing apigenin, but it did not test apigenin by itself.

Key findings

The clearest reported improvements centered on the morning adaptogen group. Because the evening product combined apigenin with magnesium L-threonate and L-theanine and there was no isolated-apigenin arm, the study cannot show whether 50 mg apigenin alone improves, worsens or has no effect on sleep.

What this study can and cannot tell us

Apigenin was bundled with two other evening ingredients, preventing ingredient-specific attribution. Participants were generally healthy and physically active, supplementation lasted only 14 days, and meal timing was not standardized. The study was funded by the finished-product manufacturer.

Citation network

Articles citing this research paper

6 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified